Paper8575331
Overexpression of a membrane protein, neuropilin, in chimeric mice causes anomalies in the cardiovascular system, nervous system and limbs.
Kitsukawa T and 4 others. Development, 1995. Cited by 333 papers, by iCite.
Cite this record
ConductScience Library. Overexpression of a membrane protein, neuropilin, in chimeric mice causes anomalies in the cardiovascular system, nervous system and limbs. Papers, record 8575331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8575331
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Overexpression of a membrane protein, neuropilin, in chimeric mice causes anomalies in the cardiovascular system, nervous system and limbs.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cardiovascular System | Major topic |
| Extremities | Major topic |
| Nerve Tissue Proteins | Major topic |
| Nervous System | Major topic |
| Animals | |
| Gene Expression | |
| Mice | |
| Mice, Transgenic | |
| Neuropilin-1 | |
| Stem Cells |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT01187212 | Sorafenib Trial in Advanced and/or Recurrent Gastric Adenocarcinoma: Treatment Evaluation: STARGATE | Background |
Source ClinicalTrials.gov
Cited by118
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 333 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42742223 | Neuropilin-1 is involved in lytic replication in a subset of primary effusion lymphoma cell lines and for KSHV gene expression in primary endothelial cells. | mBio | 2026 | https://conductscience.org/library/papers/42742223 | PubMed |
| 41355602 | Targeting NRP1 in Endothelial Cells Facilitates the Normalization of Scar Vessels and Prevents Fibrotic Scarring. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/41355602 | PubMed |
| 40801574 | Prolonged Exposure to Neonatal Hyperoxia Impairs Neuronal and Oligodendrocyte Maturation Associated with Long-Lasting Neuroinflammatory Responses in Juvenile Mice. | Cells | 2025 | https://conductscience.org/library/papers/40801574 | PubMed |
| 39668325 | Neuropilin-1 controls vascular permeability through juxtacrine regulation of endothelial adherens junctions. | Angiogenesis | 2024 | https://conductscience.org/library/papers/39668325 | PubMed |
| 39594723 | Enhancing Tumor Targeted Therapy: The Role of iRGD Peptide in Advanced Drug Delivery Systems. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39594723 | PubMed |
| 38994453 | The crosstalk between neuropilin-1 and tumor necrosis factor-α in endothelial cells. | Front Cell Dev Biol | 2024 | https://conductscience.org/library/papers/38994453 | PubMed |
| 38884751 | Congenital Coronary Blood Vessel Anomalies: Animal Models and the Integration of Developmental Mechanisms. | Adv Exp Med Biol | 2024 | https://conductscience.org/library/papers/38884751 | PubMed |
| 37894289 | The Nervous System Development Regulator Neuropilin-1 as a Potential Prognostic Marker and Therapeutic Target in Brain Cancer. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37894289 | PubMed |
| 37788099 | The semaphorin 3A/neuropilin-1 pathway promotes clonogenic growth of glioblastoma via activation of TGF-β signaling. | JCI Insight | 2023 | https://conductscience.org/library/papers/37788099 | PubMed |
| 37560522 | Identification of host receptors for viral entry and beyond: a perspective from the spike of SARS-CoV-2. | Front Microbiol | 2023 | https://conductscience.org/library/papers/37560522 | PubMed |
| 37328599 | Paradoxical expression of NRP1 in decidual stromal and immune cells reveals a novel inflammation balancing mechanism during early pregnancy. | Inflamm Res | 2023 | https://conductscience.org/library/papers/37328599 | PubMed |
| 36457009 | NRP1 inhibition modulates radiosensitivity of medulloblastoma by targeting cancer stem cells. | Cancer Cell Int | 2022 | https://conductscience.org/library/papers/36457009 | PubMed |
| 36203599 | From protein-protein interactions to immune modulation: Therapeutic prospects of targeting Neuropilin-1 in high-grade glioma. | Front Immunol | 2022 | https://conductscience.org/library/papers/36203599 | PubMed |
| 35905790 | Neuropilin-1 in the pathogenesis of preeclampsia, HIV-1, and SARS-CoV-2 infection: A review. | Virus Res | 2022 | https://conductscience.org/library/papers/35905790 | PubMed |
| 35858913 | Neuropilin 1 and its inhibitory ligand mini-tryptophanyl-tRNA synthetase inversely regulate VE-cadherin turnover and vascular permeability. | Nat Commun | 2022 | https://conductscience.org/library/papers/35858913 | PubMed |
| 35275718 | Structural basis for HCMV Pentamer recognition by neuropilin 2 and neutralizing antibodies. | Sci Adv | 2022 | https://conductscience.org/library/papers/35275718 | PubMed |
| 34961486 | Perspectives and potential approaches for targeting neuropilin 1 in SARS-CoV-2 infection. | Mol Med | 2021 | https://conductscience.org/library/papers/34961486 | PubMed |
| 34925719 | Lentiviral Mediated Expression of Soluble Neuropilin 1 Inhibits Semaphorin 3A-mediated Collapse Activity in Vitro. | Basic Clin Neurosci | 2021 | https://conductscience.org/library/papers/34925719 | PubMed |
| 34721846 | Endothelial cells are not productively infected by SARS-CoV-2. | Clin Transl Immunology | 2021 | https://conductscience.org/library/papers/34721846 | PubMed |
| 34277411 | Neuropilin-1: A Key Protein to Consider in the Progression of Pediatric Brain Tumors. | Front Oncol | 2021 | https://conductscience.org/library/papers/34277411 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| NRP1 | 8829 | PubTator's text mining | https://conductscience.org/library/genes/8829 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8575331
GET https://conductscience.org/api/papers/v1/8575331/cited_by?page=2